Agnico Eagle Mines Ltd vs AstraZeneca plc — how do they compare? Agnico Eagle Mines Ltd trades at $184.84 (market cap $92.01B), while AstraZeneca plc trades at $158.15 (market cap $248.14B). The key difference: AstraZeneca plc is far larger — about 2.7× Agnico Eagle Mines Ltd's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AEM | AZN | |
|---|---|---|
Market Cap | $92.01B | $248.14B |
Sector | Basic Materials | Health |
52-Week High | $252.19 | $209.48 |
52-Week Low | $130.23 | $147.06 |
Enterprise Value | $88.85B | $275.41B |
Dividend Yield | 0.99% | 2.01% |
Trailing returns across standard periods
Latest headlines on both assets
Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Read more on AEM →A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →